New collaboration will connect patients flagged during mobile skin cancer screenings with Rocket Doctor physicians across Ontario, Alberta, and British Columbia ●Rocket Doctor has partnered with Melanoma Canada to provide timely follow-up care for patients identified as at-risk during mobile skin cancer screenings. ●Patients without a family doctor will be directly referred to physicians on Rocket Doctor through a streamlined digital intake process.●The Mole Mobile campaign travels across Alberta, British Columbia, Ontario, and Quebec, providing free screenings in both remote and urban communities.●Skin cancer is the most common cancer in Canada, with 1 in 3 cancer diagnoses being skin-related — more than breast, prostate, lung, and colon cancers combined.●22 Canadians are diagnosed with melanoma every day, and 3 Canadians die daily from this serious form of skin cancer.●The partnership is expected to increase patient visits on Rocket Doctor’s platform, improving access to care and continuity for at-risk individuals.
Toronto, ON, May 20, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc.(CSE: TRUE, OTC: TREIF, Frankfurt: 939) ("Treatment”) is proud to announce that its virtual care subsidiary, Rocket Doctor Inc., has partnered with Melanoma Canada to help bridge the care gap for individuals identified as at-risk for melanoma and other skin cancers during mobile screening events across the country.
Melanoma Canada’s Mole Mobile units, Canada’s first mobile skin cancer screening clinics, presented by Neutrogena®, a Kenvue brand travel across Alberta, British Columbia, Ontario, and Quebec, offering free skin checks from certified dermatologists in both remote and urban communities.
The story "Rocket Doctor Partners with Melanoma Canada to Expand Access to Follow-Up Care for At-Risk Patients" has 1042 words across 29 sentences, which will take approximately 5 - 9 minutes for the average person to read.
Which news outlet covered this story?
The story "Rocket Doctor Partners with Melanoma Canada to Expand Access to Follow-Up Care for At-Risk Patients" was covered 16 hours ago by GlobeNewswire, a news publisher based in China.
How trustworthy is 'GlobeNewswire' news outlet?
GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.
The outlet is headquartered in China and publishes an average of 99 news stories per day.
It's most recent story was published 8 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
